HALOPHTHALIMIDE COMPOUNDS AND METHODS OF USE
US Application 63/397,235
Filed on 2022-08-11
Filed on 2022-08-11
MONOCLONAL ANTIBODIES DIRECTED TO THREONINE PHOSPHORYLATION OF PSD95 AND USES THEREOF
US Application 63/358,178
Filed on 2022-07-04
Filed on 2022-07-04
COMPOUNDS AND MOLECULAR TARGETS FOR TREATING AND/OR PREVENTING ALZHEIMER'S DISEASE
US Application 63/253,992
Filed on 2021-10-08
Filed on 2021-10-08
PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY
US Application 62/618,422
Filed on 2018-01-17
Filed on 2018-01-17
HUMAN INSULIN C-ALPHA-PEPTIDES AND METHODS OF USE
US Application 63/178,083
Filed on 2021-04-22
Filed on 2021-04-22
INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA
US Application 63/033,579
Filed on 2020-06-02
Filed on 2020-06-02
GINGERENONE A PRO-DRUGS AS SENOTHERAPEUTICS AND METHODS OF USE
US Application 63/302,873
Filed on 2022-01-25
Filed on 2022-01-25
INHIBITORS OF LRP1-DKK PROTEIN COMPLEX TO PROMOTE CLEARANCE OF AMYLOID-BETA
US Application 62/857,204
Filed on 2019-06-04
Filed on 2019-06-04
METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE
US Application 62/410,748
Filed on 2016-10-20
Filed on 2016-10-20
FATTY ACID DERIVATIVES AND THEIR USE
US Application 62/529,846
Filed on 2017-07-07
Filed on 2017-07-07